Clinical Trials Directory

Trials / Completed

CompletedNCT06363448

Yamani Technique Versus Proline Mesh for Intraocular Lens Scleral Fixation in Aphakia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The study aims to describe a new method of sulcus fixation of intraocular lenses (IOLs) using a prolene mesh and to compare its outcomes with Yamani technique.

Detailed description

Properly positioned posterior chamber IOL (PCIOL) offers many advantages over an anterior chamber IOL (ACIOL). The potential advantages of PCIOLs over ACIOLs include a reduction in the number of optical aberrations (e.g. magnification, aniseikonia, lens edge glare, flutter), a decreased incidence of secondary glaucoma, and free movement of the pupil to control the amount of light entering the eye. The risk for corneal decompensation, secondary glaucoma, and cystoid macular edema may be less with PCIOLs than with ACIOLs. In the absence of capsular support, many techniques have been described to secure the haptics to the sulcus region. All described techniques focus on IOL haptics fixation to the scleral wall at two or more points. These techniques are not free of complications, including IOL tilt, misalignment, myopic shift, IOL suture rupture, and dislocation. In a previous study, Othman et al compared classic ab-externo two-point IOL fixation with a new technique of IOL scleral fixation based on fashioning trans-scleral, a double rectangular suture sulcus reconstruction (DRSSR) to support the IOL optic, thus providing a cushion to the IOL being positioned in the sulcus. Aim of

Conditions

Interventions

TypeNameDescription
PROCEDUREYamani Technique versus Prolene Mesh for Intraocular Lens Scleral Fixation in AphakiaPatients were divided into two groups to undergo classic ab externo two-point scleral fixation or flanged haptics as described by Yamani or the 2\*2 proline mesh technique.

Timeline

Start date
2024-01-01
Primary completion
2024-06-30
Completion
2024-12-30
First posted
2024-04-12
Last updated
2025-05-02

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06363448. Inclusion in this directory is not an endorsement.